Validation of the Oxford classification of IgA nephropathy for pediatric patients from China

<p>Abstract</p> <p>Background</p> <p>The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.<...

Full description

Bibliographic Details
Main Authors: Le Weibo, Zeng Cai-Hong, Liu Zhangsuo, Liu Dong, Yang Qing, Lin Rui-Xia, Xia Zheng-Kun, Fan Zhong-Min, Zhu Guanghua, Wu Ying, Xu Hong, Zhai Yihui, Ding Ying, Yang Xiaoqing, Liang Shaoshan, Chen Hao, Xu Feng, Huang Qian, Shen Hongbing, Wang Jianming, Fogo Agnes B, Liu Zhi-Hong
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Nephrology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2369/13/158
id doaj-42d4f54418864a9d9bdadfafd6e5f163
record_format Article
spelling doaj-42d4f54418864a9d9bdadfafd6e5f1632020-11-25T00:37:15ZengBMCBMC Nephrology1471-23692012-11-0113115810.1186/1471-2369-13-158Validation of the Oxford classification of IgA nephropathy for pediatric patients from ChinaLe WeiboZeng Cai-HongLiu ZhangsuoLiu DongYang QingLin Rui-XiaXia Zheng-KunFan Zhong-MinZhu GuanghuaWu YingXu HongZhai YihuiDing YingYang XiaoqingLiang ShaoshanChen HaoXu FengHuang QianShen HongbingWang JianmingFogo Agnes BLiu Zhi-Hong<p>Abstract</p> <p>Background</p> <p>The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.</p> <p>Methods</p> <p>A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.</p> <p>Results</p> <p>There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).</p> <p>Conclusions</p> <p>We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.</p> http://www.biomedcentral.com/1471-2369/13/158GlomerulonephritisIgA nephropathyOxford classificationChildrenPediatrics
collection DOAJ
language English
format Article
sources DOAJ
author Le Weibo
Zeng Cai-Hong
Liu Zhangsuo
Liu Dong
Yang Qing
Lin Rui-Xia
Xia Zheng-Kun
Fan Zhong-Min
Zhu Guanghua
Wu Ying
Xu Hong
Zhai Yihui
Ding Ying
Yang Xiaoqing
Liang Shaoshan
Chen Hao
Xu Feng
Huang Qian
Shen Hongbing
Wang Jianming
Fogo Agnes B
Liu Zhi-Hong
spellingShingle Le Weibo
Zeng Cai-Hong
Liu Zhangsuo
Liu Dong
Yang Qing
Lin Rui-Xia
Xia Zheng-Kun
Fan Zhong-Min
Zhu Guanghua
Wu Ying
Xu Hong
Zhai Yihui
Ding Ying
Yang Xiaoqing
Liang Shaoshan
Chen Hao
Xu Feng
Huang Qian
Shen Hongbing
Wang Jianming
Fogo Agnes B
Liu Zhi-Hong
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
BMC Nephrology
Glomerulonephritis
IgA nephropathy
Oxford classification
Children
Pediatrics
author_facet Le Weibo
Zeng Cai-Hong
Liu Zhangsuo
Liu Dong
Yang Qing
Lin Rui-Xia
Xia Zheng-Kun
Fan Zhong-Min
Zhu Guanghua
Wu Ying
Xu Hong
Zhai Yihui
Ding Ying
Yang Xiaoqing
Liang Shaoshan
Chen Hao
Xu Feng
Huang Qian
Shen Hongbing
Wang Jianming
Fogo Agnes B
Liu Zhi-Hong
author_sort Le Weibo
title Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_short Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_full Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_fullStr Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_full_unstemmed Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_sort validation of the oxford classification of iga nephropathy for pediatric patients from china
publisher BMC
series BMC Nephrology
issn 1471-2369
publishDate 2012-11-01
description <p>Abstract</p> <p>Background</p> <p>The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.</p> <p>Methods</p> <p>A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.</p> <p>Results</p> <p>There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).</p> <p>Conclusions</p> <p>We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.</p>
topic Glomerulonephritis
IgA nephropathy
Oxford classification
Children
Pediatrics
url http://www.biomedcentral.com/1471-2369/13/158
work_keys_str_mv AT leweibo validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT zengcaihong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liuzhangsuo validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liudong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT yangqing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT linruixia validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT xiazhengkun validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT fanzhongmin validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT zhuguanghua validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT wuying validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT xuhong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT zhaiyihui validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT dingying validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT yangxiaoqing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liangshaoshan validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT chenhao validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT xufeng validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT huangqian validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT shenhongbing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT wangjianming validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT fogoagnesb validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liuzhihong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
_version_ 1725301717523759104